About 4,9-bis(4-bromophenyl)-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaene;N-(3-tert-butylphenyl)-N-[4-[9-[4-(N-(3-tert-butylphenyl)-3-phenylanilino)phenyl]-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaen-4-yl]phenyl]-3-phenylaniline;1-tert-butyl-3-[(3-phenylphenyl)methyl]benzene
4,9-bis(4-bromophenyl)-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaene;N-(3-tert-butylphenyl)-N-[4-[9-[4-(N-(3-tert-butylphenyl)-3-phenylanilino)phenyl]-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaen-4-yl]phenyl]-3-phenylaniline;1-tert-butyl-3-[(3-phenylphenyl)methyl]benzene (PubChem CID 158520979) has the molecular formula C119H96Br2N2O4
and a molecular weight of 1777.89 g/mol. Its IUPAC name is 4,9-bis(4-bromophenyl)-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaene;N-(3-tert-butylphenyl)-N-[4-[9-[4-(N-(3-tert-butylphenyl)-3-phenylanilino)phenyl]-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaen-4-yl]phenyl]-3-phenylaniline;1-tert-butyl-3-[(3-phenylphenyl)methyl]benzene.
Frequently Asked Questions
What is the IUPAC name of 4,9-bis(4-bromophenyl)-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaene;N-(3-tert-butylphenyl)-N-[4-[9-[4-(N-(3-tert-butylphenyl)-3-phenylanilino)phenyl]-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaen-4-yl]phenyl]-3-phenylaniline;1-tert-butyl-3-[(3-phenylphenyl)methyl]benzene?
The IUPAC name of 4,9-bis(4-bromophenyl)-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaene;N-(3-tert-butylphenyl)-N-[4-[9-[4-(N-(3-tert-butylphenyl)-3-phenylanilino)phenyl]-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaen-4-yl]phenyl]-3-phenylaniline;1-tert-butyl-3-[(3-phenylphenyl)methyl]benzene (CID 158520979) is 4,9-bis(4-bromophenyl)-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaene;N-(3-tert-butylphenyl)-N-[4-[9-[4-(N-(3-tert-butylphenyl)-3-phenylanilino)phenyl]-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaen-4-yl]phenyl]-3-phenylaniline;1-tert-butyl-3-[(3-phenylphenyl)methyl]benzene.
What is the SMILES notation for 4,9-bis(4-bromophenyl)-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaene;N-(3-tert-butylphenyl)-N-[4-[9-[4-(N-(3-tert-butylphenyl)-3-phenylanilino)phenyl]-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaen-4-yl]phenyl]-3-phenylaniline;1-tert-butyl-3-[(3-phenylphenyl)methyl]benzene?
The canonical SMILES for 4,9-bis(4-bromophenyl)-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaene;N-(3-tert-butylphenyl)-N-[4-[9-[4-(N-(3-tert-butylphenyl)-3-phenylanilino)phenyl]-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaen-4-yl]phenyl]-3-phenylaniline;1-tert-butyl-3-[(3-phenylphenyl)methyl]benzene is Brc1ccc(-c2cc3c4ccccc4c4cc(-c5ccc(Br)cc5)oc4c3o2)cc1.CC(C)(C)c1cccc(Cc2cccc(-c3ccccc3)c2)c1.CC(C)(C)c1cccc(N(c2ccc(-c3cc4c5ccccc5c5cc(-c6ccc(N(c7cccc(-c8ccccc8)c7)c7cccc(C(C)(C)C)c7)cc6)oc5c4o3)cc2)c2cccc(-c3ccccc3)c2)c1.
What is the InChIKey of 4,9-bis(4-bromophenyl)-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaene;N-(3-tert-butylphenyl)-N-[4-[9-[4-(N-(3-tert-butylphenyl)-3-phenylanilino)phenyl]-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaen-4-yl]phenyl]-3-phenylaniline;1-tert-butyl-3-[(3-phenylphenyl)methyl]benzene?
The InChIKey is HMEZWYXVCWPHAJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C70H58N2O2.C26H14Br2O2.C23H24/c1-69(2,3)53-25-17-29-59(43-53)71(57-27-15-23-51(41-57)47-19-9-7-10-20-47)55-37-33-49(34-38-55)65-45-63-61-31-13-14-32-62(61)64-46-66(74-68(64)67(63)73-65)50-35-39-56(40-36-50)72(60-30-18-26-54(44-60)70(4,5)6)58-28-16-24-52(42-58)48-21-11-8-12-22-48;27-17-9-5-15(6-10-17)23-13-21-19-3-1-2-4-20(19)22-14-24(30-26(22)25(21)29-23)16-7-11-18(28)12-8-16;1-23(2,3)22-14-8-10-19(17-22)15-18-9-7-13-21(16-18)20-11-5-4-6-12-20/h7-46H,1-6H3;1-14H;4-14,16-17H,15H2,1-3H3.
What are the key properties of 4,9-bis(4-bromophenyl)-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaene;N-(3-tert-butylphenyl)-N-[4-[9-[4-(N-(3-tert-butylphenyl)-3-phenylanilino)phenyl]-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaen-4-yl]phenyl]-3-phenylaniline;1-tert-butyl-3-[(3-phenylphenyl)methyl]benzene?
4,9-bis(4-bromophenyl)-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaene;N-(3-tert-butylphenyl)-N-[4-[9-[4-(N-(3-tert-butylphenyl)-3-phenylanilino)phenyl]-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaen-4-yl]phenyl]-3-phenylaniline;1-tert-butyl-3-[(3-phenylphenyl)methyl]benzene has a molecular weight of 1777.89 g/mol, XLogP of 35.97, 15 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 4,9-bis(4-bromophenyl)-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaene;N-(3-tert-butylphenyl)-N-[4-[9-[4-(N-(3-tert-butylphenyl)-3-phenylanilino)phenyl]-5,8-dioxatetracyclo[10.4.0.02,6.07,11]hexadeca-1(16),2(6),3,7(11),9,12,14-heptaen-4-yl]phenyl]-3-phenylaniline;1-tert-butyl-3-[(3-phenylphenyl)methyl]benzene is sourced from PubChem (CID 158520979), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).